Ice Hockey Players (n=24) Post-COVID-19 Controls (n=20)
Age (range), sex
26.6 (18 – 38), male 30.5 (21 – 43), male
Symptoms (any), n (%) 12 (54 %*) 19 (95 %)
Respiratory symptoms, n (%) Cough Breathlessness 8 (36 %*) 7 (88 %) 1 (12%) 16 (80 %) 16 (100 %) 2 (12 %)
Prior SARS-CoV-2 infection, n (%) 7 (29 %) 3 (15 %)
Number of vaccinations, n (%) none at least 1 1 (incomplete) 2 (basic immunization) 3 (boostered) 3 (12 %) 21 (88 %) 6 (26 %) 7 (29 %) 8 (33 %) 2 (10 %) 18 (90 %) 3 (15 %) 12 (60%) 3 (15 %)
Vaccine, n (%) Moderna (Spikevax®) Pfizer/BioNTech (Comirnaty®) Johnson & Johnson (Janssen®) 18 (86%) 3 (14%) 0 (0 %) 13 (72%) 4 (22%) 1 (6%)
Asthma, n (%) 2 (8%) 4 (21 %)
Allergic rhinitis, n (%) 3 (4%) 5 (25 %)
Regular URTI or fever, n (%) 2 (9 %**) 1 (5 %)
Recurrent herpes labialis, n (%) 5 (22 %**) 3 (16 %)